United States

Securities and Exchange Commission

Washington, D.C. 20549

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934

Filed by the Registrant ☒

Filed by a Party other than the Registrant ☐

Check the appropriate box:

☐	Preliminary Proxy Statement
☐	Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
☐	Definitive Proxy Statement
☒	Definitive Additional Materials
☐	Soliciting Materials under § 240.14a-12

ZOMEDICA CORP.

(Name of Registrant as Specified in Its Charter)

_________________________________________________________ 

(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)

Payment of Filing Fee (Check all boxes that apply):

☒	No fee required.
☐	Fee paid previously with preliminary materials.
☐	Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11

On May 29, 2025, Zomedica Corp. sent the following message to its shareholders registered with Say Technologies, LLC (“Say”) via Say’s shareholder communication platform relating to its 2025 Annual Meeting of Shareholders:

Dear Shareholder:

This Is Your Moment — Don’t Miss the Chance to Be Heard

Time is almost up. If you’ve been waiting to vote, this is your last opportunity to make it count. Proxy votes must be submitted by June 8 at 11:59 p.m. EDT—after that, the window closes, and your chance to help shape the company’s future will be gone.

The Annual Shareholder Meeting is happening virtually on June 10 at 11:00 a.m. EDT, and while the conversation will continue, your ability to impact the outcome ends in just a few days. As a retail investor, your voice is powerful. You’ve invested your money—and now we’re asking you to invest one more thing: your time.

If you believe in where we’re going, this is your chance to back it up with action. Review the materials. Hit the VOTE button. And be counted.

There’s still time—but not much. Let’s move forward together.

Vote now

	Larry Heaton   Chief Executive Officer, Zomedica
Don't want to receive shareholder messages from Zomedica? Opt out
Say Technologies LLC is a third party provider of shareholder engagement services to and on behalf of public companies. This message and its contents (collectively, this “Content”) is sent by the aforementioned issuer and provided for informational purposes only. This Content is not intended to provide financial, legal, tax or investment advice or recommendations. You are receiving this Content because you are a shareholder of the aforementioned issuer. This Content may contain insights and/or opinions that do not reflect the views of Say Technologies LLC or any of its subsidiaries or affiliates. Say Technologies LLC makes no representations or warranties as to the suitability, accuracy, completeness, or timeliness of the Content provided, including any information provided by third parties. This is an automated message. If you want to contact us, please do not reply to this message but instead send Say support a message here. Replies to this message will not be read or responded to. Read here for more information on our Privacy Policy.